Deciphering leukemic B-cell chronic lymphoproliferative disorders

References

• Thieblemont C, Nasser V, Felman P, Leroy K, Gazzo S, Callet-Bauchu E, et al. Small lymphocytic lymphoma, marginal zone B-cell lymphoma, and mantle cell lymphoma exhibit distinct gene-expression profiles allowing molecular diagnosis. Blood 2004; 103: 2727–2737
   PubMed Web of Science ®Google Scholar
• Matutes E, Owusu-Ankomah K, Morilla R, Garcia Marco J, Houlihan A, Que T H, et al. The immunological profile of B-cell disorders and proposal of a scoring system for the diagnosis of CLL. Leukemia 1994; 8: 1640–1645
   PubMed Web of Science ®Google Scholar
• Moreau E J, Matutes E, A'Hern R P, Morilla A M, Morilla R M, Owusu-Ankomah K A, et al. Improvement of the chronic lymphocytic leukemia scoring system with the monoclonal antibody SN8 (CD79b). Am J Clin Pathol 1997; 108: 378–382
   PubMed Web of Science ®Google Scholar
• Dohner H, Stilgenbauer S, Benner A, Leupolt E, Krober A, Bullinger L, et al. Genomic aberrations and survival in chronic lymphocytic leukemia. N Engl J Med 2000; 343: 1910–1916
   PubMed Web of Science ®Google Scholar
• Gazzo S, Baseggio L, Coignet L, Poncet C, Morel D, Coiffier B, et al. Cytogenetic and molecular delineation of a region of chromosome 3q commonly gained in marginal zone B-cell lymphoma. Haematologica 2003; 88: 31–38
   PubMed Web of Science ®Google Scholar
• Sanchez-Izquierdo D, Buchonnet G, Siebert R, Gascoyne R D, Climent J, Karran L, et al. Splenic marginal-zone lymphoma: a distinct clinical and pathological entity. Lancet Oncol 2003; 4: 95–103
   PubMed Web of Science ®Google Scholar
• Oscier D, Owen R, Johnson S. Splenic marginal zone lymphoma. Blood Rev 2005; 19: 39–51
   PubMed Web of Science ®Google Scholar
• Jares P, Fernandez P L, Campo E, Nadal A, Bosch F, Aiza G, et al. PRAD-1/cyclin D1 gene overexpression in chronic lymphoproliferative disorders: a highly specific marker of mantle cell lymphoma. Blood 1994; 84: 2726–2732
   PubMed Web of Science ®Google Scholar
• Criel A, Michaux L, de Wolf-Peeters C. The concept of typical and atypical chronic lymphocytic leukaemia. Leuk Lymphoma 1999; 33: 33–45
   PubMed Web of Science ®Google Scholar
• Evans W E, Cheok M, Yang W, Sherr C J. Expression arrays illuminate a way forward for mantle cell lymphoma. Cancer Cell 2003; 3: 100–102
   PubMed Web of Science ®Google Scholar
• Polyak K, Lee M H, Erdjument-Bromage H, Koff A, Roberts J M, Tempst P, et al. Cloning of p27Kip1, a cyclin-dependent kinase inhibitor and a potential mediator of extracellular antimitogenic signals. Cell 1994; 78: 59–66
   PubMed Web of Science ®Google Scholar
• Coats S, Flanagan W M, Nourse J, Roberts J M. Requirement of p27Kip1 for restriction point control of the fibroblast cell cycle. Science 1996; 272: 877–880
   PubMed Web of Science ®Google Scholar
• Kudoh S, Kumaravel T S, Kuramavel B, Eguchi M, Asaoku H, Dohy H, et al. Protein expression of cell cycle regulator, p27Kip1, correlates with histopathological grade of non-Hodgkin's lymphoma. Jpn J Cancer Res 1999; 90: 1262–1269
   PubMedGoogle Scholar
• Bennett J M, Catovsky D, Daniel M T, Flandrin G, Galton D A, Gralnick H R, et al. Proposals for the classification of chronic (mature) B and T lymphoid leukaemias. French-American-British (FAB) Cooperative Group. J Clin Pathol 1989; 42: 567–584
   PubMed Web of Science ®Google Scholar
• Jaffe E S, Harris N L, Stein H, Vardiman J W. World Health Organization Classification of Tumours. Pathology and Genetics of Tumours of Haematopoietic and Lymphoid Tissues. IARC Press, Lyon 2001
   Google Scholar
• Mitelman F. An International System for Human Cytogenetic Nomenclature. S. Karger, Basel 1995
   Google Scholar
• Uchimaru K, Taniguchi T, Yoshikawa M, Asano S, Arnold A, Fujita T, et al. Detection of cyclin D1 (bcl-1, PRAD1) overexpression by a simple competitive reverse transcription-polymerase chain reaction assay in t(11;14)(q13;q32)-bearing B-cell malignancies and/or mantle cell lymphoma. Blood 1997; 89: 965–974
   PubMed Web of Science ®Google Scholar
• Vrhovac R, Delmer A, Tang R, Marie J P, Zittoun R, Ajchenbaum-Cymbalista F. Prognostic significance of the cell cycle inhibitor p27Kip1 in chronic B-cell lymphocytic leukemia. Blood 1998; 91: 4694–4700
   PubMed Web of Science ®Google Scholar
• Letestu R, Ugo V, Valensi F, Radford-Weiss I, Nataf J, Levy V, et al. Prognostic impact of p27KIP1 expression in cyclin D1 positive lymphoproliferative disorders. Leukemia 2004; 18: 953–961
   PubMed Web of Science ®Google Scholar
• Au W Y, Horsman D E, Ohno H, Klasa R J, Gascoyne R D. Bcl-3/IgH translocation (14;19)(q32;q13) in non-Hodgkin's lymphomas. Leuk Lymphoma 2002; 43: 813–816
   PubMed Web of Science ®Google Scholar
• Montserrat E. Chronic lymphoproliferative disorders. Curr Opin Oncol 1997; 9: 34–41
   PubMedGoogle Scholar
• Stone R M. Prolymphocytic leukemia. Hematol Oncol Clin North Am 1990; 4: 457–471
   PubMed Web of Science ®Google Scholar
• Troussard X, Valensi F, Duchayne E, Garand R, Felman P, Tulliez M, et al. Splenic lymphoma with villous lymphocytes: clinical presentation, biology and prognostic factors in a series of 100 patients. Groupe Francais d'Hematologie Cellulaire (GFHC). Br J Haematol 1996; 93: 731–736
   PubMed Web of Science ®Google Scholar
• Troussard X, Maloisel F, Flandrin G. Hairy cell leukemia. What is new 40 years after the first description?. Hematol Cell Ther 1998; 40: 139–148
   PubMedGoogle Scholar
• Matutes E, Polliack A. Morphological and immunophenotypic features of chronic lymphocytic leukemia. Rev Clin Exp Hematol 2000; 4: 22–47
   PubMedGoogle Scholar
• Berland R, Wortis H H. Origins and functions of B-1 cells with notes on the role of CD5. Annu Rev Immunol 2002; 20: 253–300
   PubMed Web of Science ®Google Scholar
• Chiorazzi N, Ferrarini M. B cell chronic lymphocytic leukemia: lessons learned from studies of the B cell antigen receptor. Annu Rev Immunol 2003; 21: 841–894
   PubMed Web of Science ®Google Scholar
• Orchard J, Garand R, Davis Z, Babbage G, Sahota S, Matutes E, et al. A subset of t(11;14) lymphoma with mantle cell features displays mutated IgVH genes and includes patients with good prognosis, nonnodal disease. Blood 2003; 101: 4975–4981
   PubMed Web of Science ®Google Scholar
• Peghini P E, Fehr J. Analysis of cyclin D1 expression by quantitative real-time reverse transcription-polymerase chain reaction in the diagnosis of mantle cell lymphoma. Am J Clin Pathol 2002; 117: 237–245
   PubMed Web of Science ®Google Scholar
• Nowakowski G S, Dewald G W, Hoyer J D, Paternoster S F, Stockero K J, Fink S R, et al. Interphase fluorescence in situ hybridization with an IGH probe is important in the evaluation of patients with a clinical diagnosis of chronic lymphocytic leukaemia. Br J Haematol 2005; 130: 36–42
   PubMed Web of Science ®Google Scholar
• Frater J L, McCarron K F, Hammel J P, Shapiro J L, Miller M L, Tubbs R R, et al. Typical and atypical chronic lymphocytic leukemia differ clinically and immunophenotypically. Am J Clin Pathol 2001; 116: 655–664
   PubMed Web of Science ®Google Scholar
• Delgado J, Matutes E, Morilla A M, Morilla R M, Owusu-Ankomah K A, Rafiq-Mohammed F, et al. Diagnostic significance of CD20 and FMC7 expression in B-cell disorders. Am J Clin Pathol 2003; 120: 754–759
   PubMed Web of Science ®Google Scholar
• Bigoni R, Cuneo A, Roberti M G, Bardi A, Rigolin G M, Piva N, et al. Chromosome aberrations in atypical chronic lymphocytic leukemia: a cytogenetic and interphase cytogenetic study. Leukemia 1997; 11: 1933–1940
   PubMed Web of Science ®Google Scholar
• Criel A, Verhoef G, Vlietinck R, Mecucci C, Billiet J, Michaux L, et al. Further characterization of morphologically defined typical and atypical CLL: a clinical, immunophenotypic, cytogenetic and prognostic study on 390 cases. Br J Haematol 1997; 97: 383–391
   PubMed Web of Science ®Google Scholar
• Matutes E, Oscier D, Garcia-Marco J, Ellis J, Copplestone A, Gillingham R, et al. Trisomy 12 defines a group of CLL with atypical morphology: correlation between cytogenetic, clinical and laboratory features in 544 patients. Br J Haematol 1996; 92: 382–388
   PubMed Web of Science ®Google Scholar
• Schwaenen C, Nessling M, Wessendorf S, Salvi T, Wrobel G, Radlwimmer B, et al. Automated array-based genomic profiling in chronic lymphocytic leukemia: development of a clinical tool and discovery of recurrent genomic alterations. Proc Natl Acad Sci USA 2004; 101: 1039–1044
   PubMed Web of Science ®Google Scholar